TNNC1 (P63316) variants and mutations
TNNC1 (also known as P63316) is a human protein-coding gene encoding a troponin C, slow skeletal and cardiac muscles protein. It binds calcium during each heartbeat and shifts the troponin complex to permit actin-myosin interaction and force generation in cardiac muscle. Pathogenic variants can alter calcium sensitivity and cause hypertrophic or dilated cardiomyopathy. This analysis covers 434 TNNC1 variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes hypertrophic cardiomyopathy, cardiomyopathy, familial restrictive, 1, and dilated cardiomyopathy 1FF. Example TNNC1 variants include D2G, D2N, and D2V.
Variant analysis overview
- Gene: TNNC1
- Protein: P63316
- UniProt accession: P63316
- Organism: Homo sapiens
- Variants analyzed: 434
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 209 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 46 synonymous variants; 149 missense variants; 10 stop-gained variants; 9 frameshift variants; 4 in-frame deletions; 2 in-frame insertions; 6 substitution
- Prediction scores: 339 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hypertrophic cardiomyopathy, cardiomyopathy, familial restrictive, 1, dilated cardiomyopathy 1FF, dilated cardiomyopathy 2A, hypertrophic cardiomyopathy 7, familial isolated dilated cardiomyopathy, Rare familial disorder with hypertrophic cardiomyopathy, familial isolated restrictive cardiomyopathy, cardiomyopathy, Abnormality of the cardiovascular system, familial hypertrophic cardiomyopathy, dilated cardiomyopathy.
Protein structure and variant hotspots
- Protein features: 4 domains; 15 binding sites; 2 post-translational modification sites.
- Structural context: 399 variants have structural context.
- PTM context: 8 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable TNNC1 variants
Examples include D2G, D2N, D2V, D3G, D3N, D3V, I4M, I4T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- D2G (p.Asp2Gly), rs397516850, ClinGen CA134863, ClinVar RCV000037769, ClinVar RCV002354193, AlphaMissense 0.23, MetaLR 0.22, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- D2N (p.Asp2Asn), rs886058707, ClinGen CA10619226, ClinVar RCV000312255, ClinVar RCV000398459, AlphaMissense 0.15, MetaLR 0.23, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; not specified
- D2V (p.Asp2Val), rs397516850, ClinGen CA353170984, ClinVar RCV002932127, AlphaMissense 0.23, MetaLR 0.22, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- D3G (p.Asp3Gly), rs730881063, ClinGen CA353170942, ClinVar RCV002295165, AlphaMissense 0.49, MetaLR 0.36, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- D3N (p.Asp3Asn), rs2153230088, ClinGen CA353170975, ClinVar RCV001372143, Ensembl rs2153230088, AlphaMissense 0.29, MetaLR 0.36, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- D3V (p.Asp3Val), rs730881063, ClinGen CA297337, ClinVar RCV000159203, Ensembl rs730881063, AlphaMissense 0.49, MetaLR 0.36, Likely pathogenic, not provided
- I4M (p.Ile4Met), rs1706370994, ClinGen CA353170893, ClinVar RCV003315472, Pathogenic, Dilated cardiomyopathy 1Z
- I4T (p.Ile4Thr), rs2153230086, ClinGen CA353170903, ClinVar RCV001756494, Ensembl rs2153230086, AlphaMissense 0.30, MetaLR 0.14, Uncertain significance, not provided
- Y5* (p.Tyr5Ter), TOPMed rs1294584228, gnomAD rs1294584228
- Y5C (p.Tyr5Cys), rs1706370933, ClinGen CA353170873, ClinVar RCV001891689, ClinVar RCV006555105, AlphaMissense 0.49, MetaLR 0.22, Conflicting interpretations, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- K6R (p.Lys6Arg), rs2153230085, ClinGen CA353170842, ClinVar RCV001364666, ClinVar RCV002413865, AlphaMissense 0.10, MetaLR 0.18, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; Cardiovascular phenot
- A7V (p.Ala7Val), rs776926378, []
- A8G (p.Ala8Gly), rs267607125, ClinGen CA353170797, ClinVar RCV002014274, gnomAD rs267607125, AlphaMissense 0.45, MetaLR 0.68, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- A8V (p.Ala8Val), rs267607125, ClinGen CA122397, ClinVar RCV000013256, ClinVar RCV000037762, REVEL 0.23, CADD 23.10, Conflicting interpretations, Cardiovascular phenotype; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy
- V9G (p.Val9Gly), rs730881056, ClinGen CA297307, ClinVar RCV000159192, ClinVar RCV000468842, AlphaMissense 0.39, MetaLR 0.69, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; not provided
- V9I (p.Val9Ile), rs1578264552, ClinGen CA353170074, ClinVar RCV000853119, ClinVar RCV002427090, AlphaMissense 0.28, MetaLR 0.66, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z; Cardiovascular phenot
- Q11H (p.Gln11His), Ensembl rs1706343999
- T13K (p.Thr13Lys), TOPMed rs1221201947, gnomAD rs1221201947
- E14* (p.Glu14Ter), NCI-TCGA Cosmic COSV9923, Variant assessed as somatic; high impact.
- E15* (p.Glu15Ter), TOPMed rs1253857789, gnomAD rs1253857789
- E15K (p.Glu15Lys), TOPMed rs1253857789, gnomAD rs1253857789
- K17T (p.Lys17Thr), rs2153229989, ClinGen CA353169889, ClinVar RCV001362489, Ensembl rs2153229989, AlphaMissense 0.62, MetaLR 0.86, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- N18K (p.Asn18Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- N18S (p.Asn18Ser), TOPMed rs1706343846, Uncertain significance, Cardiovascular phenotype
- N18T (p.Asn18Thr), rs1706343846, ClinGen CA353169851, ClinVar RCV002347247, ClinVar RCV006559050, AlphaMissense 0.09, MetaLR 0.61, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z; Cardiovascular phenot
- E19D (p.Glu19Asp), rs2471444734, ClinGen CA353169691, ClinVar RCV004265064, Uncertain significance, Cardiovascular phenotype
- K21T (p.Lys21Thr), gnomAD rs1408270420
- A22E (p.Ala22Glu), rs2471444718, ClinGen CA353169629, ClinVar RCV003019136, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- A22S (p.Ala22Ser), rs2471444722, ClinGen CA353169634, ClinVar RCV003448922, ClinVar RCV004992609, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; Cardiovascular phenot
- A22V (p.Ala22Val), rs2471444718, ClinGen CA353169611, ClinVar RCV002364560, ClinVar RCV003776285, Uncertain significance, Cardiovascular phenotype; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy
- A23D (p.Ala23Asp), rs1559616263, ClinGen CA353169586, ClinVar RCV000685102, Ensembl rs1559616263, AlphaMissense 1.00, MetaLR 0.95, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- F24L (p.Phe24Leu), ExAC rs751682878, gnomAD rs751682878, Likely benign
- D25N (p.Asp25Asn), rs730881064, ClinGen CA297340, NCI-TCGA Cosmic COSV5176, ClinVar RCV000159205, AlphaMissense 0.28, MetaLR 0.65, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- p.Val28 Gly29insLys, gnomAD 19-55156362-C-CTT, CADD 9.30
- V28V (p.Val28Val), gnomAD 19-55156362-C-A, CADD 10.50
- V28G (p.Val28Gly), rs1428949969, gnomAD 19-55156363-A-C, CADD 5.68
- V28W (p.Val28Trp), gnomAD 19-55156363-AC-A, CADD 0.12
- V28L (p.Val28Leu), gnomAD 19-55156364-C-G, CADD 0.30
- V28M (p.Val28Met), rs1281040826, gnomAD 19-55156364-C-T, CADD 0.37
- L29Q (p.Leu29Gln), rs267607123, ClinGen CA122395, ClinVar RCV000013255, ClinVar RCV000215162, AlphaMissense 0.15, MetaLR 0.59, Uncertain significance, Cardiovascular phenotype; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy
- L29P (p.Leu29Pro), rs2085729878, gnomAD 19-55156348-A-G, CADD 2.92
- L29V (p.Leu29Val), rs1013144337, gnomAD 19-55156349-G-C, CADD 1.50
- L29F (p.Leu29Phe), gnomAD 19-55156349-G-A, CADD 1.79
- L29H (p.Leu29His), gnomAD 19-55156349-GGGAA, CADD 5.17
- L29I (p.Leu29Ile), gnomAD 19-55156349-G-T, CADD 1.43
- G30L (p.Gly30Leu), gnomAD 19-55156359-GCC-G, CADD 0.64
- G30G (p.Gly30Gly), gnomAD 19-55156359-G-A, CADD 7.72
- G30A (p.Gly30Ala), gnomAD 19-55156360-C-G, CADD 1.02
- G30D (p.Gly30Asp), rs1330144062, gnomAD 19-55156360-C-T, CADD 1.24
- G30S (p.Gly30Ser), gnomAD 19-55156361-C-T, CADD 1.93
- A31S (p.Ala31Ser), rs397514616, ClinGen CA130608, ClinVar RCV000033053, ClinVar RCV003764652, CADD 4.28, Pathogenic, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- A31T (p.Ala31Thr), rs397514616, ClinGen CA297310, ClinVar RCV000159193, ClinVar RCV001306036, CADD 4.94, Uncertain significance, not provided; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- A31E (p.Ala31Glu), rs201422579, gnomAD 19-55156276-G-T, CADD 7.29
- A31G (p.Ala31Gly), rs201422579, gnomAD 19-55156276-G-C, CADD 8.47
- A31V (p.Ala31Val), rs1057518784, gnomAD 19-55156289-G-A, REVEL 0.47, CADD 22.00
- A31D (p.Ala31Asp), gnomAD 19-55156354-G-T, CADD 6.67
- E32K (p.Glu32Lys), rs1553651750, ClinGen CA353169283, ClinVar RCV000647104, ClinVar RCV003162940, REVEL 0.45, CADD 22.80, Uncertain significance, Cardiovascular phenotype; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy
- D33N (p.Asp33Asn), rs727503494, ClinGen CA178252, ClinVar RCV000152067, Ensembl rs727503494, AlphaMissense 0.24, MetaLR 0.90, Uncertain significance, not specified
- G34R (p.Gly34Arg), rs2471444684, ClinGen CA353169184, ClinVar RCV003315276, Pathogenic
- C35Y (p.Cys35Tyr), gnomAD rs1410998674
- C35* (p.Cys35Ter), gnomAD 19-55156320-G-T, REVEL 0.47, CADD 23.70
- C35F (p.Cys35Phe), gnomAD 19-55156324-C-A, CADD 15.80
- C35S (p.Cys35Ser), rs2085729640, gnomAD 19-55156327-C-G, CADD 14.70
- C35W (p.Cys35Trp), rs2085729924, gnomAD 19-55156356-G-C, CADD 1.56
- C35C (p.Cys35Cys), gnomAD 19-55156356-G-A, CADD 1.85
- S37G (p.Ser37Gly), rs2471444670, ClinGen CA353169049, ClinVar RCV003129367, Uncertain significance, not provided
- S37N (p.Ser37Asn), NCI-TCGA Cosmic COSV5176, Variant assessed as somatic; moderate impact.
- S37S (p.Ser37Ser), gnomAD 19-55156350-G-A, CADD 7.65
- S37Y (p.Ser37Tyr), gnomAD 19-55156351-G-T, CADD 2.94
- K39R (p.Lys39Arg), rs2471444659, ClinGen CA353168964, ClinVar RCV002329852, ClinVar RCV003775845, Uncertain significance, not provided; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- L41M (p.Leu41Met), rs2471444658, ClinGen CA353168914, ClinVar RCV002820170, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- L41P (p.Leu41Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L41R (p.Leu41Arg), rs1438878332, gnomAD 19-55156330-A-C, CADD 12.80
- L41F (p.Leu41Phe), rs786204398, gnomAD 19-55156340-G-A, CADD 8.86
- L41I (p.Leu41Ile), gnomAD 19-55156340-G-T, CADD 12.70
- G42D (p.Gly42Asp), rs1706339623, ClinGen CA353168891, ClinVar RCV001314095, Ensembl rs1706339623, AlphaMissense 0.99, MetaLR 0.71, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- K43R (p.Lys43Arg), gnomAD 19-55156306-T-C, CADD 14.20
- V44G (p.Val44Gly), Ensembl rs1578264331
- V44M (p.Val44Met), rs1706339531, ClinGen CA353168840, ClinVar RCV001328482, ClinVar RCV002546259, AlphaMissense 0.92, MetaLR 0.63, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- M45I (p.Met45Ile), rs2471444636, ClinGen CA353168797, ClinVar RCV003486530, ClinVar RCV005406043, Conflicting interpretations, Cardiovascular phenotype; Dilated cardiomyopathy 1Z
- M45V (p.Met45Val), rs2471444639, ClinGen CA353168834, ClinVar RCV003810156, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- R46K (p.Arg46Lys), rs3729710, gnomAD 19-55156285-C-T, CADD 12.90
- R46Q (p.Arg46Gln), rs2147284967, gnomAD 19-55156288-C-T, CADD 6.76
- R46L (p.Arg46Leu), gnomAD 19-55156288-C-A, CADD 6.30
- R46P (p.Arg46Pro), gnomAD 19-55156295-C-G, REVEL 0.64, CADD 24.50
- R46* (p.Arg46Ter), rs1286340820, gnomAD 19-55156296-G-A, CADD 40.00
- R46R (p.Arg46Arg), gnomAD 19-55156365-C-T, CADD 3.60
- M47I (p.Met47Ile), rs886039440, ClinGen CA353168720, ClinVar RCV003802698, ClinGen CA10588371, AlphaMissense 0.92, MetaLR 0.48, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- M47R (p.Met47Arg), rs1553651744, ClinGen CA353168723, ClinVar RCV000577999, ClinVar RCV000578078, AlphaMissense 0.94, MetaLR 0.40, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- L48P (p.Leu48Pro), Ensembl rs897557713
- L48M (p.Leu48Met), gnomAD 19-55156329-G-T, REVEL 0.70, CADD 26.60
- G49V (p.Gly49Val), rs3729711, gnomAD 19-55156279-C-A, CADD 12.40
- Q50H (p.Gln50His), rs2471444628, ClinGen CA353168631, ClinVar RCV003801279, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- N51K (p.Asn51Lys), rs1057518507, ClinGen CA16042521, ClinVar RCV000413622, Ensembl rs1057518507, AlphaMissense 0.91, MetaLR 0.50, Uncertain significance, not specified
- P52L (p.Pro52Leu), rs730881065, ClinGen CA353168551, ClinVar RCV001052549, Ensembl rs730881065, AlphaMissense 0.96, MetaLR 0.45, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- P52R (p.Pro52Arg), rs730881065, ClinGen CA297343, ClinVar RCV000586385, ClinVar RCV000647106, AlphaMissense 0.96, MetaLR 0.45, Conflicting interpretations, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- P52S (p.Pro52Ser), rs2471444623, ClinGen CA353168555, ClinVar RCV003341687, Uncertain significance, Cardiovascular phenotype
- P52H (p.Pro52His), gnomAD 19-55156342-G-T, CADD 9.66
- P52T (p.Pro52Thr), rs1345623490, gnomAD 19-55156343-G-T, CADD 10.50
- P52Q (p.Pro52Gln), gnomAD 19-55156345-G-T, CADD 1.47
- T53A (p.Thr53Ala), rs1553651742, ClinGen CA353168547, ClinVar RCV000647107, ClinVar RCV000825474, AlphaMissense 0.42, MetaLR 0.52, Uncertain significance, not specified; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- T53I (p.Thr53Ile), rs2471444614, ClinGen CA353168506, ClinVar RCV003024150, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- T53N (p.Thr53Asn), rs2471444614, ClinGen CA353168510, ClinVar RCV002398394, Uncertain significance, Cardiovascular phenotype
- P54H (p.Pro54His), rs876661393, ClinGen CA10581146, ClinVar RCV000223755, ClinVar RCV000483835, AlphaMissense 0.54, MetaLR 0.39, Conflicting interpretations, not provided
- P54P (p.Pro54Pro), rs397516343, gnomAD 19-55156237-C-A, CADD 7.35
- P54Q (p.Pro54Gln), rs752503819, gnomAD 19-55156238-G-T, REVEL 0.82, CADD 28.50
- P54R (p.Pro54Arg), rs752503819, gnomAD 19-55156238-G-C, REVEL 0.85, CADD 28.70
- P54T (p.Pro54Thr), gnomAD 19-55156239-G-T, REVEL 0.75, CADD 25.10
- P54S (p.Pro54Ser), rs77615401, gnomAD 19-55156239-G-A, REVEL 0.76, CADD 28.40
- E55D (p.Glu55Asp), Ensembl rs1706338992
- E55K (p.Glu55Lys), rs2471444605, ClinGen CA353168438, ClinVar RCV002810545, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- E55R (p.Glu55Arg), rs781712996, ClinGen CA2438578, ClinVar RCV003070860, Uncertain significance
- E55G (p.Glu55Gly), gnomAD 19-55156294-T-C, CADD 9.03
- E56D (p.Glu56Asp), rs199523612, ClinGen CA353168338, ClinVar RCV001377540, ExAC rs199523612, AlphaMissense 0.58, MetaLR 0.67, Likely pathogenic, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- L57M (p.Leu57Met), gnomAD 19-55156302-G-T, REVEL 0.35, CADD 21.40
- L54del (p.Leu54del), gnomAD 19-55156319-TGCA-, CADD 22.80
- L57L (p.Leu57Leu), rs1555864068, gnomAD 19-55156323-G-A, CADD 16.30
- L57P (p.Leu57Pro), gnomAD 19-55156325-A-G, REVEL 0.93, CADD 32.00
- Q58Q (p.Gln58Gln), gnomAD 19-55156240-C-T, CADD 13.60
- Q58R (p.Gln58Arg), rs2085728568, gnomAD 19-55156241-T-C, REVEL 0.31, CADD 23.60
- Q58K (p.Gln58Lys), gnomAD 19-55156242-G-T, REVEL 0.29, CADD 23.60
- Q58E (p.Gln58Glu), rs2085729446, gnomAD 19-55156308-G-C, REVEL 0.20, CADD 19.40
- Q58P (p.Gln58Pro), rs775512887, gnomAD 19-55156319-T-G, REVEL 0.80, CADD 26.40
- E59K (p.Glu59Lys), rs2471444594, ClinGen CA353168254, ClinVar RCV002299277, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- E59Q (p.Glu59Gln), rs776162352, gnomAD 19-55156305-C-G, REVEL 0.66, CADD 24.00
- M60I (p.Met60Ile), rs1471808574, ClinGen CA353168219, ClinVar RCV001315280, ClinVar RCV001751605, AlphaMissense 0.94, MetaLR 0.48, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- I61M (p.Ile61Met), rs764114178, ClinGen CA353168135, ClinVar RCV002295721, ClinVar RCV005288753, Uncertain significance, Cardiovascular phenotype; Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy
- I61T (p.Ile61Thr), rs545441942, gnomAD 19-55156316-A-G, REVEL 0.56, CADD 22.90
- D62E (p.Asp62Glu), rs1553651734, ClinGen CA353168102, ClinVar RCV001313693, Ensembl rs1553651734, AlphaMissense 0.49, MetaLR 0.29, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- D62H (p.Asp62His), TOPMed rs1040079072, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- D62N (p.Asp62Asn), rs1040079072, ClinGen CA74776012, ClinVar RCV000491866, ClinVar RCV001039174, AlphaMissense 0.30, MetaLR 0.30, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; Cardiovascular phenot
- D62Y (p.Asp62Tyr), rs1040079072, ClinGen CA353168132, ClinVar RCV003338181, AlphaMissense 0.30, MetaLR 0.30, Uncertain significance, Dilated cardiomyopathy 1Z
- E63* (p.Glu63Ter), gnomAD rs1366764544
- E63A (p.Glu63Ala), rs2471444576, ClinGen CA353168079, ClinVar RCV003800334, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- E63D (p.Glu63Asp), rs864622721, ClinGen CA349665, ClinVar RCV000205502, ClinVar RCV004020547, AlphaMissense 0.62, MetaLR 0.52, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- E63G (p.Glu63Gly), rs2085729352, gnomAD 19-55156298-T-C, REVEL 0.85, CADD 33.00
- V64A (p.Val64Ala), rs730881057, ClinGen CA297313, ClinVar RCV000159194, Ensembl rs730881057, AlphaMissense 0.85, MetaLR 0.46, Uncertain significance, not provided
- D65E (p.Asp65Glu), rs370426309, ClinGen CA353167991, ClinVar RCV001352246, ESP rs370426309, AlphaMissense 0.99, MetaLR 0.91, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- D65G (p.Asp65Gly), gnomAD rs1706338500
- D65N (p.Asp65Asn), Ensembl rs868818979
- E66K (p.Glu66Lys), rs1706338420, ClinGen CA353167962, ClinVar RCV001324642, Ensembl rs1706338420, REVEL 0.34, CADD 22.90, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- E67del (p.Glu67del), gnomAD 19-55156281-GCTC-, CADD 22.00
- E66V (p.Glu66Val), rs760401006, gnomAD 19-55156283-T-A, REVEL 0.38, CADD 23.90
- E66* (p.Glu66Ter), gnomAD 19-55156284-C-A, CADD 42.00
- E66D (p.Glu66Asp), rs3729710, gnomAD 19-55156285-C-A, REVEL 0.35, CADD 18.30
- E66A (p.Glu66Ala), gnomAD 19-55156286-T-G, REVEL 0.31, CADD 23.00
- E66Q (p.Glu66Gln), rs1253836774, gnomAD 19-55156287-C-G, REVEL 0.28, CADD 22.80
- G68S (p.Gly68Ser), rs1267940563, ClinGen CA353167879, NCI-TCGA Cosmic COSV5176, ClinVar RCV002011291, AlphaMissense 0.38, MetaLR 0.46, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z
- S69R (p.Ser69Arg), rs202173903, ClinGen CA16611461, ClinVar RCV000470675, 1000Genomes rs202173903, AlphaMissense 0.99, MetaLR 0.61, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- S69S (p.Ser69Ser), rs1243719576, gnomAD 19-55156252-G-A, CADD 13.80
- S69I (p.Ser69Ile), gnomAD 19-55156253-C-A, REVEL 0.60, CADD 22.60
- S69N (p.Ser69Asn), rs1276999572, gnomAD 19-55156282-C-T, CADD 13.40
- G70D (p.Gly70Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G70S (p.Gly70Ser), rs772752716, ClinGen CA2438552, ClinVar RCV001299003, ClinVar RCV002246289, AlphaMissense 0.77, MetaLR 0.94, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- G70A (p.Gly70Ala), gnomAD 19-55156265-C-G, REVEL 0.56, CADD 20.30
- G70R (p.Gly70Arg), rs1170054667, gnomAD 19-55156266-C-G, REVEL 0.55, CADD 22.60
- G70G (p.Gly70Gly), gnomAD 19-55156273-T-C, CADD 14.90
- T71M (p.Thr71Met), rs1706331809, ClinGen CA353167606, ClinVar RCV002418873, ClinVar RCV004799622, AlphaMissense 0.28, MetaLR 0.49, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- T71T (p.Thr71Thr), gnomAD 19-55156249-G-T, CADD 6.85
- T71I (p.Thr71Ile), rs786205288, gnomAD 19-55156250-G-A, REVEL 0.25, CADD 23.00
- T71S (p.Thr71Ser), rs786204399, gnomAD 19-55156251-T-A, REVEL 0.20, CADD 21.10
- V72A (p.Val72Ala), rs2471444258, ClinGen CA353167584, ClinVar RCV002825642, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
- F74C (p.Phe74Cys), rs1318170964, ClinGen CA353167549, ClinVar RCV001313770, ClinVar RCV002223299, AlphaMissense 0.97, MetaLR 0.76, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; not provided
- D75E (p.Asp75Glu), rs776989897, ClinGen CA2438547, ClinVar RCV003341688, ClinVar RCV005228011, AlphaMissense 0.17, MetaLR 0.17, Uncertain significance, Cardiovascular phenotype; Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy
- E76D (p.Glu76Asp), gnomAD 19-55156231-C-A, REVEL 0.20, CADD 15.30
- E76Q (p.Glu76Gln), rs759523214, gnomAD 19-55156233-C-G, REVEL 0.25, CADD 16.70
- E76* (p.Glu76Ter), rs759523214, gnomAD 19-55156233-C-A, CADD 39.00
- L78L (p.Leu78Leu), rs1302084143, gnomAD 19-55156236-G-A, CADD 11.00
- L78Q (p.Leu78Gln), gnomAD 19-55156256-A-T, REVEL 0.83, CADD 28.80
- L78V (p.Leu78Val), gnomAD 19-55156257-G-C, REVEL 0.75, CADD 25.10
- M80K (p.Met80Lys), gnomAD rs1706331444
- M81I (p.Met81Ile), rs545564444, ClinGen CA2438545, ClinVar RCV002223414, ClinVar RCV002454590, AlphaMissense 0.99, MetaLR 0.55, Uncertain significance, not provided
- M81L (p.Met81Leu), rs2471444234, ClinGen CA353167425, ClinVar RCV002450387, ClinVar RCV003775240, Uncertain significance, Hypertrophic cardiomyopathy 13; Dilated cardiomyopathy 1Z; Cardiovascular phenot
- M81T (p.Met81Thr), rs771216638, ClinGen CA2438546, ClinVar RCV000389539, ClinVar RCV001855084, AlphaMissense 0.99, MetaLR 0.73, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13; not provided
- V82V (p.Val82Val), rs2085716325, gnomAD 19-55154759-G-A, CADD 7.29
- V82L (p.Val82Leu), gnomAD 19-55154794-C-A, REVEL 0.31, CADD 22.90
- V104del (p.Val104del), gnomAD 19-55154801-CACA-, CADD 21.00
- V82E (p.Val82Glu), gnomAD 19-55154802-A-T, REVEL 0.78, CADD 29.80
- V82M (p.Val82Met), rs2147283722, gnomAD 19-55154803-C-T, REVEL 0.46, CADD 24.30
- R83G (p.Arg83Gly), rs2153229934, ClinGen CA353167382, ClinVar RCV003799171, AlphaMissense 0.81, MetaLR 0.72, Uncertain significance, Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
Public TNNC1 analysis runs
- TNNC1 analysis run — TNNC1 (434 variants) — completed 2026-08-21